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SUMMARY
About seventy years ago, steroidal hormones (see Figure l) were isolated from e.g. urine and
testis extracts and their chemical structures were subsequently identified. Investigators wanted to
use these steroids for clinical purposes like oral contraception and hormone replacement therapy,
but the bioavailability of these endogenous steroids was very low after oral administration. The
steroids were inactivated very quickly by metabolism in the gastrointestinal tract and liver. Most
steroids are very lipophilic substances, which are transformed enzymatically by a variety of
pathways into polar, water-soluble, and more readily excreted metabolites. This process is called
biotransformation.
Figure I Structures ofestradiol (left), progesterone (middle) and testosterone (right)
Because of the low oral bioavailability of the natural steroids, synthetic steroidal hormones
with estrogenic, progestagenic or androgenic activity were developed for clinical purposes. These
synthetic steroids are generally structurally related to the endogenous teroids. Substituents, e.g.
an alkyl moiety or halogens, are introduced at metabolically sensitive positions of the molecule,
to decrease the rate ofbiotransformation and, as a result, to increase the oral bioavailability ofthe
steroids. Chapter 2 of this thesis presents a summary of the known metabolic routes (with the
enzymes involved) of four synthetic, structurally related steroidal hormones, norethisterone,
levonorgestrel, desogestrel and gestodene widely used for oral contraception and hormone
replacement therapy. In addition, a general overview of the biotransformation enzymes primarily
involved in the metabolism of steroids is given in this chapter. To date, data on the metabolism of
these synthetic steroids are far from complete. Thus, a further extension of the knowledge on the
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metabolism of these synthetic steroids and enzymes responsible for their biotransformation is of
major importance for the design of new metabolically more stable steroidal compounds. The aim
of the present Ph.D. study (see Chapter 1) was to contribute to the knowledge on the metabolism
of synthetic steroidal hormones and the enzymes involved in their biotransformation in man. To
achieve these objectives, two approaches were applied.
The first part of this thesis (Section 1; Chapters 3 and 4) describes the human in vitro
metabolism of five structurally related steroids, which was investigated in order to gain insight
into the relationship between chemical structures and their metabolism. In addition, the
cytochrome P450 enzyme(s) involved in the phase I metabolism of these steroids were identified.
Quantum mechanical computeÍ calculations as well as molecular modeling studies were
performed to support the experimentally observed phase I reactions for all steroids.
ln Section 2 (Chapters 5, 6, 7 and 8) the lr viíro and in vivo metabolism of two structurally
related steroidal hormones is investigated in several species including man, in order to gain
insight into the predictability of metabolic routes found with li't ,i/ro systems for the in vivo
situation, and to determine which species is most representative for steroid metabolism in man.
Section I
In Chapter 3, the human cytochrome P450 enzyme(s) involved in the phase I metabolism of
Org 30659 and Org 4060 were investigated. In incubations with human liver microsomes both
steroids were hydroxylated at the 6B-position. Different in vitro approaches were used to establish
the involvement of the CYP3A family in the 6B-hydroxylation of these steroids. Quantum
mechanical calculations revealed that for both compounds the relative energy requirement for the
proton abstraction from the C6 position is much lower than for proton abstraction from any other
position. This finding suggests that the steric and electrostatic onstraints of the CYP3A4 active
site are flexible enough to allow hydroxylation of Org 30659 and Org 4060 at their most reactive
site. Docking of the steroidal compounds into the active site of a CYP3A4 homology model
showed that both steroids complement he putative active site of CYP3A4 in an orientation likely
leading to 6p-hydroxylation.
In Chapter 3, the human in vitro metabolism of three other synthetic steroidal hormones,
etonogestrel, levonorgestrel and gestodene (see Figure 2) and the type of cy'tochrome P450
enzyme(s) involved in their phase I metabolism in human liver microsomes was investigated in
Chapter 4. For etonogestrel, three metabolites were identified, the 6B-OH metabolite, the
13-CHzCHzOH metabolite and a l6-OH metabolite (o or B unknown). Levonorgestrel was, like
etonogestrel, also hydroxylated to the 13-CHzCH2OH metabolite and a 16-OH metabolite. In
addition, the formation of a I3-CHOHCH: metabolite was observed for levonorgestrel in
incubations with human liver microsomes. Similar to levonorgestrel, gestodene was hydroxylated
to the l3-CHOHCH3 metabolite. Results from several in yitro studies demonstrated the
involvement of the CYP3A family in the formation of all these oxidative metabolites. Evaluation
of the relative energies of the various radical species formed after hydrogen abstraction at
different carbon Postl
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different carbon positions of the three steroidal compounds, revealed again that C6 is the most
favorable site for hydrogen abstraction. Thus, regioselectivity of hydroxylation reactions for
etonogestrel, levonorgestrel and gestodene seems to be determined by specific interactions within
the active site of the CYP3A4 enzyme. Results from molecular modeling studies of etonogestrel,
levonorgestrel and gestodene into the active site of a homology model of CYP3A4 indeed
suggested that interaction energies between the ligand and the CYP3A4 active site for these





Structures of the steroidal hormones invesrigated in secíion I .
In summary, the results in Section 1 demonstrate that the presence or absence of certain
substituents on the molecule of our steroidal hormones has considerable influence on their
metabolism. Results from several in vitro studies, strongly suggest hat the CYP3A family plays a
significant role in the phase I metabolism of the five synthetic steroidal hormones. Quantum
mechanical calculations combined with homology modeling can be used to explain the
experimentally observed regioselectivity of the CYP3A4 caïalyzed biotransformation of the
synthetic steroidal hormones investigated.
Sectie 2
Because of ethical constraints, metabolism studies have to be performed either in laboratory
animals or in vitro systems with human tissue, before performing in vivo metabolism studies in
humans. \ffhen using laboratory animals and in vitro systems to study the metabolism of the
synthetic steroidal hormones, it is impor.tant o establish which species is most suitable for proper
prediction of the metabolism of steroids in man and to gain insight into the predictabilify of the in
yitro systems for the in vivo situation. Chapters 5 and 6 describe the in vítro and in vivo




Metabolism was examined in vivo after orai administration to laboratory animals (rat, dog or
monkey) and in yitro using liver microsomes and hepatocl.tes from several species including man.
In yitro biotransformation routes observed in incubations with human liver microsomes or
hepatocy.tes were used to predict the in vivo metabolic routes for these synthetic steroidal
hormones in humans. The in vitro-br ylvo correlations obtained for the laboratory animals were
taken into account to strengthen these extrapolations. Finally, the metabolism of Org 30659 and
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Figure 3 Structures oflhe sÍeroidal hormones investigated insection 2.
Results in Chapter 5 and Chapter 6 showed that desogestrel and Org 30659 were
extensively metabolized after oral administration to laboratory animals. Both phase I and phase II
biotransformation routes were observed for desogestrel and Org 30659. However, in vívo
metabolism of desogestrel in rat was very different in comparison with metabolism in dog.
Significant differences in the lir vlvo metabolism between rats and monkeys were also found for
Org 30659. Results from ln vllro studies revealed that incubations with liver microsomes of
rabbits and monkeys were in good agreement with the metabolism of desogestrel and Org 30659
in human liver microsomes and hepatocl'tes.
Metabolism studies in healthy postmenopausal women showed that desogestrel and
Org 30659 were also extensively metabolized after oral administration to humans. Conjugation
with glucuronic acid was a major metabolic route for both desogestrel and Org 30659. In
addition, several hydroxylated metabolites were found for desogestrel, but not for Org 30659. The
6B-OH metabolite of Org 30659 observed in human preparations in vilro was not observed to a
significant extent in plasma, urine or feces of postmenopausal women. Consequently, the
extrapolation of the results from in vilro studies with human liver material only, did not provide
an adequate prediction of the ln vlvo metabolic routes of Org 30659 in women. Explanations for
the observed discrepancy between in viíro and in vivo metaboiism of Org 30659 may be the
choice of the substrate concentration for the in vitro study or possibly extrahepatic metabolism.
For desogestrel on the other hand, ín vivo meïabolic routes in humans were readily predicted from
in vitro metaboiism studies with human material.
In conciusion, the prediction of the in vivo metabolic routes of desogestrel and Org 30659,
based on the results from the in vitro studies performed for these steroids with liver tissue
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(microsomes or hepatocytes) only, is still far from straightforward. Since both phase I and
phase II metabolic reactions are important in the metabolism of the synthetic steroidal hormones,
intact cell systems such as isolated hepatocytes or slices might be the most suitable in vitro
system. However, the influence of incubation conditions (e.g. substrate concentration) has to be
further investigated.
Species comparison of the metabolic routes of desogestrel after oral administration showed
that neither the rat nor the dog seems a satisfactory model for desogestrel metabolism in humans.
Species comparison with regard to the metabolism of Org 30659 indicates that metabolism of
Org 30659 in rat differs from its metabolism in humans, whereas the metabolism of Org 30659 in
monkey showed several similarities to the human metabolic profile. So, the data of this thesis
suggest hat the monkey seems to be a better representative than the rat and dog for metabolism of
steroidal hormones in humans. However, funher studies are needed to generalize this finding.
Finally, metabolism studies with desogestrel and Org 30659 reveal that despite the
comparable chemical structures, striking differences in the metabolic routes were found for these
steroidal hormones in several species. This finding is in agreement with the results in Section 1,
that the presence or absence of certain substituents on the molecule of our steroidal hormones has
considerable influence on their phase I metabolism. In Section 1, it was also demonstrated that
computational techniques could be used to explain the experimentally observed regioselectivity of
the CYP3A4 catalyzed biotransformation of the steroidal hormones. Since other enzymes, like
glucuronosyltransferases, also play an important role in the biotransformation of steroids, it is
important to develop models that can give more insight into the role of these enzymes in human
metabolism of the steroidal hormones.
The research described in this thesis was performed at the Department of Toxicology and
Drug Disposition, NV Organon, Oss, The Netherlands in cooperation with the DepaÍment of
Pharmacokinetics and Drug Delivery, University of Groningen, The Netherlands and the
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